Referral and adjuvant treatment patterns after nephrectomy in high‐risk locoregional renal cell carcinoma-Reference-Cited by-同舟云学术

Referral and adjuvant treatment patterns after nephrectomy in high‐risk locoregional renal cell carcinoma

Published:2021-11-09 Issue:24 Volume:10 Page:8891-8898
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Dzimitrowicz Hannah¹^ORCID,Esterberg Elizabeth²,Miles LaStella²,Zanotti Giovanni³,Borham Azah³,Harrison Michael R.¹

Affiliation:

1. Division of Medical Oncology Department of Medicine Duke Cancer Institute Duke University Durham North Carolina USA

2. RTI Health Solutions Research Triangle Park North Carolina USA

3. Pfizer Inc New York New York USA

Funder

Pfizer

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4407

Reference24 articles.

1. National Cancer Institute. Renal Cell Cancer Treatment (PDQ®)–Health Professional Version. US Department of Health and Human Services National Institutes of Health. Last update: 17 March 2021. Accessed 30 June 2021.https://www.cancer.gov/types/kidney/hp/kidney‐treatment‐pdq#_228_toc

2. HowladerN NooneAM KrapchoM et al. SEER Cancer Statistics Review (CSR) 1975–2016. National Cancer Institute. Last update: 9 April 2020. Accessed 16 February 2021.https://seer.cancer.gov/csr/1975_2016/

3. NCCN Guidelines Insights: Kidney Cancer, Version 1.2021

4. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease

5. Patterns of recurrence and surveillance strategies for renal cell carcinoma following surgical resection

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolving Role of Adjuvant Systemic Therapy for Kidney and Urothelial Cancers;American Society of Clinical Oncology Educational Book;2022-07